Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTLI.L Regulatory News (TLI)

  • There is currently no data for TLI

Interim Management Statement

19 Nov 2013 16:15

RNS Number : 4452T
Alternative Asset Opps PCC Ltd
19 November 2013
 



 

 

19 November 2013

Alternative Asset Opportunities PCC Limited

(the "Company")

Interim Management Statement

 

This interim management statement relates to the period from 1 July 2013 to the date of publication of this statement and has been prepared solely to provide additional information in order to meet the relevant requirement of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

The Company is a closed-ended Guernsey registered protected cell company with one cell known as the US Traded Life Interests Fund (the "Fund").

 

Investment objective

The Company's investment objective in respect of the Fund is to provide investors with an attractive capital return through investment predominantly in a diversified portfolio of US Traded Life Interests ("TLIs").

 

Financial position and performance

The original published net asset value per share as at 30 June 2013 was 55.6 pence, but the Annual Report and Accounts adjusted this figure to 48.5 pence, a reduction of 12.8%, and explained the reasons for this change. Over the period to 31 October 2013, the Company's net asset value per share decreased by 1.9% from the adjusted figure to 47.6 pence. As at 31 October 2013, the shares were trading at a 13.9% discount to the net asset value. 

 

Five policy maturities on five lives were identified during the period. The gain from one policy maturity was recognised in the 31 July 2013 NAV adding circa 2.1 pence to the NAV per share. The gains from the other four policy maturities were recognised in the 31 October 2013 NAV, adding a total of 1.5 pence to the NAV per share. There have been, in aggregate, 50 policy maturities since the Fund's inception.

 

The Company's loan agreement with Allied Irish Banks plc is due to expire on 31 March 2014. The Company is currently in the process of negotiating a renewal of the loan agreement beyond that date. As at 18 November 2013, following repayment of the above maturity proceeds, there are no borrowings under the agreement and the cash balance stands at $1,708,096.

 

 

Material events and transactions in the period and since 31 October 2013

 

At the Annual General Meeting held on 13 November 2013 an ordinary resolution was passed to approve the continuance of the US Traded Life Interests Fund of the Company until the Annual General Meeting to be held in 2014.

The Board is not aware of any other material events during the period from 1 July 2013 to 31 October 2013, or in the period from 1 November 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

The tables below aim to give investors an appreciation of the effects of differing assumptions to both LE and IRR.

- The first line of NAVs in the table uses the 'Latest LE' assumption, that is to say either an LE based on a recently updated assessment (obtained on or after 1 April 2013), or for the remaining policies an adjusted LE based on the most recent LE obtained, increased by 12%. The average LE is shown for reference (4.9 years). NAV is then shown at four different discount rates, ranging from 10% to 20%. This shows the effect of IRR on current value, and it allows investors to assess the effects of policy sales if, for example, the portfolio was to be liquidated.

 

- The second line shows the effect of a further increase of one year in the valuation LEs.

 

- The third line shows the effect of a decrease of one year in the valuation LEs.

 

 

- Finally, the fourth line shows the outcome of assuming LEs are simply based on the current table of life expectancies for the general population, the 2008 Valuation Basic Table, i.e. ignoring LE assessments.

 

Sensitivity Matrix

Net Asset Value in pence per share on various assumptions as at 31 October 2013

 

Mortality Assumptions

Average LE

Discount Rates applied to cash flows

10%

Current (12%)

16%

20%

Latest LE

4.9

50.7

47.6

42.4

38.3

+1 year for all LEs

5.9

37.7

34.9

30.5

27.1

- 1 year for all LEs

3.9

65.1

61.8

56.2

51.6

Using 2008 VBT

5.0

50.4

47.2

41.8

37.6

 

 

Source: SL Investment Management Limited

 

Distribution of Life Expectancy estimates

 

The following table shows the distribution by LE band of the death benefit and number of lives in the portfolio. Lives are grouped by 6 month LE bands and the table shows the number of lives and the total death benefit in each group. The LEs are the valuation LEs used for the 31 October 2013 valuation.

 

It is important to note that the LE is an average of the estimated length of future lifetime for an individual with a given age and health status. The table is not, therefore, a prediction of when actual maturities will occur and is thus not a cashflow forecast.

 

 

LE Band (Years)

Number of Lives

Death Benefit

0 ≤ LE < 0.5

0

$ -

0.5 ≤ LE < 1

0

$ -

1 ≤ LE < 1.5

0

$ -

1.5 ≤ LE < 2

1

$ 1,300,000

2 ≤ LE < 2.5

2

$ 5,500,000

2.5 ≤ LE < 3

1

$ 2,000,000

3 ≤ LE < 3.5

5

$ 11,450,000

3.5 ≤ LE < 4

10

$ 14,036,918

4 ≤ LE < 4.5

16

$ 26,109,334

4.5 ≤ LE < 5

8

$ 13,075,240

5 ≤ LE < 5.5

14

$ 30,650,000

5.5 ≤ LE < 6

8

$ 9,714,265

6 ≤ LE < 6.5

6

$ 8,861,438

6.5 ≤ LE < 7

7

$ 12,401,195

7 ≤ LE < 7.5

3

$ 11,000,000

7.5 ≤ LE < 8

2

$ 2,500,000

LE ≥ 8

2

$ 3,000,000

Total

85

 $ 151,598,390

 

 

 

Top ten holdings

By reference to the most recent portfolio valuation of the Company as at 31 October 2013, the largest ten investments held by the Company, measured by life office exposure, were as follows:

 

 

 

 

Issuer

Number of policies

% of totalassets as at31 October 2013

American General Life Insurance Company (TX)

10

20.35%

Lincoln National Life Insurance Co

14

18. 32%

Transamerica Life Insurance Company

18

16.21%

Massachusetts Mutual Life Insurance Co

5

7.55%

MetLife Insurance Company of Connecticut

6

5.02%

Security Life of Denver Insurance Co

1

4.84%

John Hancock Life Insurance Company

6

4.48%

New York Life Insurance and Annuity Corp

5

4.08%

Aviva Life and Annuity Company of NY

4

3.95%

Genworth Life Insurance Company

1

2.47%

 

Company Information

 

Launch date 25 March 2004

EPIC TLI

Year end 30 June

Report & Accounts 2013 Annual Report posted October, Half-yearly posted February

AGM November

Price Information Financial Times (under INVESTMENT COMPANIES, listed as 'AltAstsOpps.')

 

Investor Information

 

The latest available portfolio information included in the interim and annual report and accounts can be accessed via www.allianzgi.co.uk/TLI (under the Professional Investors section).

 

By order of the Board

Alternative Asset Opportunities PCC Limited

 

Enquiries:

Peter Ingram

Company Secretary Tel: 020 7065 1467

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGGWGGUPWGQB
Date   Source Headline
4th Dec 20133:43 pmRNSListing Rule 15.6.8
19th Nov 20134:15 pmRNSInterim Management Statement
15th Nov 20131:26 pmRNSNet Asset Value(s)
13th Nov 20132:27 pmRNSResult of AGM
8th Nov 20133:06 pmRNSHolding(s) in Company
4th Nov 20139:28 amRNSListing Rule 15.6.8
1st Nov 20134:44 pmRNSChange of Name of Investment Manager
15th Oct 201312:35 pmRNSNet Asset Value(s)
3rd Oct 20131:13 pmRNSNet Asset Value(s)
2nd Oct 20134:05 pmRNSListing Rule 15.6.8
2nd Oct 20137:00 amRNSFinal Results
3rd Sep 201310:17 amRNSListing Rule 15.6.8
19th Aug 20135:26 pmRNSHolding(s) in Company
19th Aug 20134:13 pmRNSHolding(s) in Company
19th Aug 201312:38 pmRNSHolding(s) in Company
19th Aug 20139:28 amRNSNet Asset Value(s)
2nd Aug 201310:29 amRNSListing Rule 15.6.8
26th Jul 201312:36 pmRNSPortfolio Update
15th Jul 20133:29 pmRNSNet Asset Value(s) - Replacement
15th Jul 20139:54 amRNSNet Asset Value(s)
12th Jul 201312:17 pmRNSDirector Declaration
2nd Jul 201312:02 pmRNSListing Rule 15.6.8
17th Jun 201310:31 amRNSNet Asset Value(s)
4th Jun 201311:35 amRNSListing Rule 15.6.8
16th May 201312:27 pmRNSNet Asset Value(s)
10th May 201311:04 amRNSInterim Management Statement
2nd May 201310:38 amRNSListing Rule 15.6.8
16th Apr 201311:25 amRNSNet Asset Value(s)
3rd Apr 201311:33 amRNSListing Rule 15.6.8
15th Mar 201311:36 amRNSNet Asset Value(s)
4th Mar 201310:28 amRNSListing Rule 15.6.8
28th Feb 20138:14 amRNSHalf Yearly Report
21st Feb 20138:03 amRNSDirector/PDMR Shareholding
21st Feb 20138:02 amRNSDirectorate Change
15th Feb 201312:07 pmRNSNet Asset Value(s)
7th Feb 201312:36 pmRNSDirector Declaration
4th Feb 201311:33 amRNSListing Rule 15.6.8
15th Jan 20132:45 pmRNSNet Asset Value(s)
14th Dec 20123:10 pmRNSDirector/PDMR Shareholding
14th Dec 201210:41 amRNSNet Asset Value(s)
6th Dec 20121:25 pmRNSListing Rule 15.6.8
19th Nov 20124:22 pmRNSInterim Management Statement
14th Nov 20121:15 pmRNSResult of AGM
12th Nov 20122:15 pmRNSNet Asset Value(s)
6th Nov 20124:35 pmRNSHolding(s) in Company
5th Nov 201211:12 amRNSDirector/PDMR Shareholding
5th Nov 201211:06 amRNSDirector/PDMR Shareholding
2nd Nov 201210:02 amRNSListing Rule 15.6.8
1st Nov 201212:17 pmRNSResult of EGM
26th Oct 20121:31 pmRNSResult of Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.